long QT syndrom. Other specified conduction disorders
Conditions
Interventions
Intervention 1: Intervention Group 1: Ondansetron( 0.2 milligram per kilogram). Intervention 2: Intervention Group2: Dexamethason (0.1 milligram per kilogram). Intervention 3: Control Group: Patient's
Treatment - Drugs
Intervention Group 1: Ondansetron( 0.2 milligram per kilogram)
Intervention Group2: Dexamethason (0.1 milligram per kilogram)
Control Group: Patient's baseline ECG before administration of drugs
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients aged 6 months to 18 years candidate for cochlear implantation. Exclusion criteria: Known case of jervell lange nielson syndrome; patients with any cardiac disease; ECG abnormalities; electrolyte abnormalities; usage of drugs which prolong the QT interval and family history of QT prolongation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prolonged QT interval. Timepoint: 5 and 15 minutes after drug administrationd. Method of measurement: ECG monitoring and calculated by the cardiologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vomit. Timepoint: After the surgery. Method of measurement: inspection.;Nausea. Timepoint: After the surgery. Method of measurement: inspection.;Prolonged Tp-e interval. Timepoint: 5 and 15 minutes after drug administration. Method of measurement: ECG monitoring and calculated by the cardiologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Reza Safaeian
Rasool Akram Hospital
Outcome results
None listed